Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Biological: KB-GDT-01 Sponsors: Kiromic BioPharma Inc.; Stiris Research Inc; Statistics& Data Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Non-Small Cell Lung Cancer | Research | Statistics | Study